Emyria Ltd (ASX:EMD) MD Michael Winlo tells Proactive the company will collaborate with The Pax Centre (PAX) to develop a scalable care program for the safe provision of MDMA-assisted therapy for patients with treatment-resistant PTSD. This collaboration with Australia’s leading multidisciplinary, psychiatrist-led clinical service specialising in complex trauma treatment, feeds into EMD’s long-term goal to establish a network of trained therapists and psychiatrists to provide MDMA-assisted therapy.
Emyria thrilled with new collaboration for MDMA-assisted PTSD therapy
